Biomerica (BMRA) Depreciation & Amortization (CF) (2010 - 2026)
Biomerica (BMRA) posted Depreciation & Amortization (CF) of $20000.0 for Q1 2026, little changed sequentially from $20000.0 in Q4 2025, and down 4.76% YoY from $21000.0 in Q1 2025.
Biomerica (BMRA) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Biomerica has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $20000.0 in Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 4.76% year-over-year to $20000.0 in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $83000.0 (down 3.49% YoY) and the FY2025 annual result came in at $87000.0, up 7.41% from the prior year.
- Depreciation & Amortization (CF) held at $20000.0 in Q1 2026 per BMRA's latest filing, from $20000.0 in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $236728.0 in Q2 2022 and troughed at $18000.0 in Q1 2023.
- A 5-year average of $34254.8 and a median of $21000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) surged 441.5% in 2022, then plunged 92.4% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $19000.0 in 2022, then decreased by 5.26% to $18000.0 in 2023, then climbed by 22.22% to $22000.0 in 2024, then dropped by 9.09% to $20000.0 in 2025, then changed by 0.0% to $20000.0 in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $20000.0, $20000.0, and $20000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 20,000.00 |
| Feb 28, 2026 | 20,000.00 |
| Nov 30, 2025 | 20,000.00 |
| Nov 30, 2025 | 20,000.00 |
| Aug 31, 2025 | 20,000.00 |
| Aug 31, 2025 | 20,000.00 |
| May 31, 2025 | 23,000.00 |
| May 31, 2025 | 23,000.00 |
| Feb 28, 2025 | 21,000.00 |
| Feb 28, 2025 | 21,000.00 |
| Nov 30, 2024 | 22,000.00 |
| Nov 30, 2024 | 22,000.00 |
| Aug 31, 2024 | 21,000.00 |
| Aug 31, 2024 | 21,000.00 |
| May 31, 2024 | 22,000.00 |
| May 31, 2024 | 22,000.00 |
| Feb 29, 2024 | 20,000.00 |
| Feb 29, 2024 | 20,000.00 |
| Nov 30, 2023 | 18,000.00 |
| Nov 30, 2023 | 18,000.00 |